granted
on 23 Feb 2024
Last Applicant/ Owned by
86 Morris Avenue
Summit
NJ
07901
Serial Number
88822036 filed on 05th Mar 2020
Registration Number
N/A
Correspondent Address
Marilyn F. Kelly
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloprolRead More
Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; Pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer, cytokine inhibitory drugs; Pharmaceutical preparations for human use that modulate the immune system; Pharmaceutical and biological preparations for human use for immunotherapy, namely, T Cell therapy; Pharmaceutical preparations for human use, namely, stem cells for medical or clinical use
No 88822036
No Service/Collective Mark
No 00138753-US
No
No
No
No
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 24th Feb 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 23rd Feb 2024 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 23rd Feb 2024 | SOU EXTENSION 5 GRANTED |
| 07th Feb 2024 | SOU TEAS EXTENSION RECEIVED |
| 07th Feb 2024 | SOU EXTENSION 5 FILED |
| 31st Aug 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 29th Aug 2023 | SOU TEAS EXTENSION RECEIVED |
| 29th Aug 2023 | SOU EXTENSION 4 FILED |
| 29th Aug 2023 | SOU EXTENSION 4 GRANTED |
| 15th Mar 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
